UnitedHealth Group

UNH
Delayed Nyse - 07/19 10:00:19 pm
256.65USD
-1.52%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 226 247 242 689
EBITDA 19 772 22 003
Operating profit (EBIT) 17 344 19 365
Pre-Tax Profit (EBT) 15 944 17 614
Net income 11 986 13 586
P/E ratio 20,4x 18,3x
EPS ( $ ) 12,2 14,1
Dividend per Share ( $ ) 3,45 4,15
Yield 1,38% 1,62%
Reference price ( $ ) 249,120 256,650
Announcement Date 01/15/2019
10:55am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 25 688 23 931
Finance - -
Operating income (EBITDA) 19 772 22 003
Leverage
(Debt/EBITDA)
1,30x 1,09x
Capital Expenditure 2 063 2 215
Book Value Per Share (BVPS) ( $ ) 53,9 61,7
Cash Flow per Share ( $ ) 16,0 17,9
Announcement Date 01/15/2019
10:55am
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 243 906 M $ -
Entreprise Value (EV) 267 836 M $ 264 466 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 18,3x 16,2x
Capitalization / Revenue 1,01x 0,93x
EV / Revenue 1,10x 1,02x
EV / EBITDA 12,2x 10,9x
Yield (DPS / Price) 1,62% 1,84%
Price to book (Price / BVPS) 4,16x 3,75x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 7,98% 8,38%
Operating Leverage (Delta EBIT / Delta Sales) 1,60x 1,70x
Net Margin (Net Profit / Revenue) 5,60% 5,79%
ROA (Net Profit / Asset) 8,83% 9,33%
ROE (Net Profit / Equities) 24,8% 25,6%
Rate of Dividend 29,5% 29,7%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,91% 0,92%
Cash Flow / Sales 7,02% 6,99%
Capital Intensity (Assets / Sales) 0,63x 0,62x
Financial Leverage (Net Debt / EBITDA) 1,09x 0,83x
Price Earning Ratio
BNA & Dividende